Salmeterol

CHEMBL1263 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

415.6 g/mol

LogP

3.9

Phase

4

A long-acting bronchodilator taken twice daily to keep the airways open and prevent breathing symptoms in asthma and COPD. Unlike quick-relief inhalers, it is not intended for sudden attacks but rather for ongoing daily control of breathing difficulties.

Masse moléculaire

415,6000 g/mol

LogP

3,90

TPSA

82,00 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Respiratory Disease Asthma Chronic Obstructive Pulmonary Disease Obesity Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O

InChI

InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2

Molecular Formula

C25H37NO4

HBD / HBA

4 / 5

Liaisons Rotatives

16

Atomes Lourds

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A long-acting bronchodilator taken twice daily to keep the airways open and prevent breathing symptoms in asthma and COPD. Unlike quick-relief inhalers, it is not intended for sudden attacks but rather for ongoing daily control of breathing difficulties.

Yes, Salmeterol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1263. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5152. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Salmeterol sur PillFYI

Structure

Données Clés

Formule: C25H37NO4
Synonymes: 7

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.